Introduction {#Sec1}
============

Partial ventilatory assistance minimizes adverse effects of controlled mechanical ventilation, such as excessive sedation and ventilator-induced diaphragm dysfunction \[[@CR1]-[@CR3]\]. The most widely used partial ventilatory assistance mode is pressure support ventilation (PSV) \[[@CR4]\], in which a constant preset level of pressure assists each inspiration, regardless of the patient's inspiratory effort. Mismatching between patient demand and level of assistance is therefore possible and can be potentially harmful: underassistance may induce respiratory discomfort \[[@CR5]\], and overassistance may cause lung overdistention and volutrauma \[[@CR6]\]. Of note, underassistance and overassistance may both generate patient-ventilator asynchrony that is associated with poorer clinical outcomes \[[@CR7]\].

Proportional Assisted Ventilation (PAV) and Neurally Adjusted Ventilatory Assist (NAVA) have been designed to overcome this weakness of PSV. These two modes adjust proportionally the amount of assistance delivered. NAVA adjusts ventilator assistance to the electrical activity of the diaphragm (EAdi), recorded with an esophageal catheter \[[@CR8]\]. PAV adjusts ventilator assistance to the activity of respiratory muscles estimated by an algorithm \[[@CR9]\]. Previous studies have shown the potential benefits of PAV and NAVA to prevent the risk of overassistance \[[@CR10]-[@CR13]\], to increase the variability of the breathing pattern \[[@CR14]-[@CR20]\], and to improve patient-ventilator interaction and synchrony \[[@CR11],[@CR12],[@CR21]-[@CR26]\]. PAV and NAVA have been previously compared with PSV but not with each other. This comparison would be clinically relevant, as these two modes have their own specific strengths and weaknesses \[[@CR9],[@CR27]\].

In the study reported here, we hypothesized that PAV and NAVA improve patient-ventilator interaction in similar ways. The aim of this study was therefore to compare, in patients recovering from acute respiratory failure, the respective impacts of various levels of NAVA, PAV, and PSV on four major features of patient-ventilator interaction: (1) breathing pattern, including prevention of overassistance; (2) respiratory drive; (3) breathing pattern variability, and (4) patient-ventilator synchrony.

Materials and methods {#Sec2}
=====================

The study was conducted over a period of 3 months in a 10-bed Intensive Care Unit (ICU) in an 1,800-bed university hospital. The protocol was approved by the *Comite de Protection des Personnes* Ile de France VI. Informed consent was obtained from patients or relatives.

Patients {#Sec3}
--------

Patients initially intubated and ventilated in the ICU were eligible for inclusion in the study if (1) they had been ventilated for acute respiratory failure *via* an endotracheal tube for more than 48 hours, (2) the condition that had required mechanical ventilation had improved (in particular, the ability to trigger the ventilator with an FiO~2~ of ≤50% and positive end-expiratory pressure (PEEP) ≤5 cmH~2~O), (3) sedation had been stopped for more than 6 hours, (4) hemodynamic stability was achieved without vasopressor or inotropic medication. Exclusion criteria were known or suspected phrenic nerve dysfunction or other neuromuscular disorders that may involve the diaphragm or impair respiratory drive. Patients with contraindications to EAdi catheter placement (for example, gastroesophageal varices or obstruction, recent gastroesophageal surgery, facial surgery or trauma, or upper gastrointestinal bleeding) were excluded. Patients in whom the decision had been made to withhold life-sustaining treatment were also ineligible for inclusion.

Ventilation equipment {#Sec4}
---------------------

The conventional nasogastric tube was removed and replaced by a 16 Fr EAdi catheter (Maquet Critical Care, Solna, Sweden), and its position was controlled according to the manufacturer's recommendations \[[@CR28]\]. PSV and NAVA were delivered by using a Servo-I ventilator (Maquet Critical Care), and PAV+ was delivered by using a PB840 ventilator (Covidien, Boulder, CO, USA). Male and female patients were ventilated with an 8- and 7.5-mm internal diameter endotracheal tube, respectively.

Study protocol {#Sec5}
--------------

Inspiratory pressure support level was initially titrated to obtain a tidal volume (V~T~) of 6 to 8 ml/kg of predicted ideal body weight. Flow-trigger sensitivity was set at the lowest possible level without inducing autotriggering, and cycling-off was set at 30% of peak inspiratory flow (default value). This level of assistance was defined as PSV~100~. Patients were then switched to NAVA, and the corresponding NAVA level to obtain a similar V~T~ of 6 to 8 ml/kg was determined during a 5-minute period. This NAVA level was termed NAVA~100~. Patients were finally switched to PAV, and the percentage unloading (%Assist) was set also to obtain a similar V~T~ of 6 to 8 ml/kg. This %Assist corresponded to PAV~100~. In each of the three modes, the assist level was further decreased by 50%, corresponding to PSV~50~, NAVA~50~, and PAV~50~ and then increased by 50%, corresponding to PSV~150~, NAVA~150~, and PAV~150~. In the Results section, PSV~100,~ NAVA~100~, and PAV~100~ define a medium assistance level also termed level~100~; PSV~50,~ NAVA~50~, and PAV~50~ define a low assistance level, also termed level~50~; and PSV~150,~ NAVA~150~, and PAV~150~ define a high assistance level also termed level~150~. Of note, inspiratory pressure-support level in PSV~50~ could not be lower than 7 cmH~2~O. A high upper pressure limit at 45 cmH~2~O was set in PAV and NAVA.

Positive end-expiratory pressure (PEEP) and inspired oxygen fraction (FiO~2~) were maintained constant throughout the study period at the values in use before patient enrollment. The endotracheal tube was suctioned before the beginning of each trial. Each patient underwent three 30-minute trials, in each mode, consisting of 20-minute stabilization followed by 10-minute recording stored on a computer for further analysis. The three modes were applied in computer-generated random order. At the end of each trial, arterial blood was sampled for gas analysis (Radiometer ABL 330, Tacussel, Copenhagen, Denmark) via a catheter, and dyspnea was rated by using a visual analogue scale when possible.

Data acquisition {#Sec6}
----------------

Flow was measured with a heated Fleisch pneumotachograph, dead space 51 ml (Hans Rudolph, Kansas City, MO, USA) and airway pressure was measured by a pressure transducer (DP 15--32, Validyne, Northridge, CA, USA) for all modes. Digital EAdi signal was converted into an analog signal (National Instruments, Austin, TX, USA). During all three modes of ventilation, the EAdi waveform was simultaneously recorded with flow and airway pressure from the respective ventilator (see Additional file [1](#MOESM1){ref-type="media"}). All signals were digitized at a 100-Hz sampling rate (PowerLab/4SP, ADInstruments, Castle Hill, Australia) and recorded on a personal computer for subsequent analysis (Chart software, ADInstruments, Castle Hill, Australia).

Data analysis {#Sec7}
-------------

### Respiratory Parameters and Breathing Pattern {#Sec8}

Neural respiratory rate (RR), V~T~, duration of pneumatic inspiration (Ti), maximum EAdi, (EAdi~max~), area under the curve of EAdi during inspiratory time (EAdi~AUC~, integrated from baseline to peak), and the V~T~-(ml/kg)/Eadi~max~ ratio were calculated offline from the 10-minute airway flow and EAdi recordings. The coefficient of variation (standard deviation divided by the mean) for both flow (CV~VT~) and EAdi-related variables (CV~EAdimax~) was calculated. Maximum (P~max~) and mean inspiratory airway pressure (P~mean~) were measured and calculated from airway pressure recordings.

### Patient-ventilator interaction {#Sec9}

Within the three modes and in all conditions, correlations between EAdi~max~ and P~max~ and between EAdi~AUC~ and V~T~ were calculated. The inspiratory trigger delay was measured as the time difference between the beginning of the increase in the EAdi signal and the beginning of the ventilator inspiratory flow. The expiratory trigger delay was measured as the time difference between EAdi~max~ and the end of the insufflation, as defined by a ventilator inspiratory flow equal to zero. Using the EAdi waveform, we quantified the three main types of asynchronies accordingly to previously published definitions \[[@CR7],[@CR25]\] (see also Additional file [2](#MOESM2){ref-type="media"}): (1) ineffective efforts; (2) auto-triggering, and (3) double triggering. Of note, only type II double triggering, defined as one neural inspiration triggering two breath cycles, was considered \[[@CR25]\] (see example in Additional file [3](#MOESM3){ref-type="media"}). The number of each type of asynchrony was reported as the total number of each event per minute. A global asynchrony index (AI) was computed \[[@CR7]\].

Statistical analysis {#Sec10}
--------------------

Statistical analysis was performed with Prism 4.01 software (GraphPad Software, San Diego, CA, USA). Normality testing failed for all results (Kolmogorov-Smirnov). Results are therefore expressed as median (25 to 75 interquartile range). Within each of the three assistance level groups (that is, level~50~, level~100~, and level~150~), Friedman ANOVA for repeated measures was performed to compare breathing pattern, variability, prevalence of the main asynchronies and blood gases measured with PAV, NAVA, and PSV, respectively. Comparison between the three modes was followed, when appropriate, by a pairwise comparison by using the Dunn *post/hoc* test. The relationships among both EAdi~max~ and P~max~ and EAdi~AUC~ and V~T~ were examined by using a linear regression analysis, and the coefficient of correlation (r^2^) was determined. Differences were considered significant when the probability p of a type I error was less than 5%.

Results {#Sec11}
=======

The study pertains to a convenience sample of 16 patients (10 males). Their main characteristics and the precipitating factor of acute respiratory failure are summarized in Table [1](#Tab1){ref-type="table"}. Respective assistance levels used for each mode are reported in Table [2](#Tab2){ref-type="table"}. Of note, three patients had chronic obstructive pulmonary disease (COPD) (patients 5, 7, and 16).Table 1**Patient characteristics at enrollmentPatient no.Age (years)BMI (kg.m** ^**−2**^ **)SAPS 2Admission diagnosisMV duration before inclusion (days)FiO** ~**2**~**PEEP (cmH** ~**2**~ **O)**17032.061Pneumonia80.5429029.963ARDS20.4538316.055ARDS60.5446737.656Pneumonia120.5557727.847Acute respiratory failure due to decompensation of COPD70.5466027.535Pneumonia80.5476025.026Acute respiratory failure due to decompensation of COPD70.5488133.249Pneumonia40.4497418.463Pneumonia60.54106423.597Pneumonia110.55116723.051ARDS120.54126222.884ARDS70.54136225.049Pneumonia20.55146629.467Acute respiratory failure due to decompensation of COPD210.55156526.072Pneumonia120.55166731.646Pneumonia20.45**Median (IQR)67 (63--75)27 (23--30)55 (48--64)7.0 (5.5-11.0)0.5 (0.5-0.5)4 (4--5)**M, male; F, female; BMI, body mass index; SAPS II, Simplified Acute Physiology Score II; MV, mechanical ventilation; PEEP, positive end-expiratory pressure; IQR, interquartile range; ARDS, acute respiratory distress syndrome, COPD, chronic obstructive pulmonary disease.Table 2**Assistance levels in each experimental conditionMode, assistance settingLevel** ~**50**~**Level** ~**100**~**Level** ~**150**~**Notes**PSV, inspiratory pressure (cmH~2~O)7.0 (7.0-7.2)14.0 (11.5-15.2)21.0 (17.2-21.7)The inspiratory pressure support level, set by the clinician, is kept constant regardless of the mechanical properties of the lung/thorax and patient effort.NAVA, NAVA level (cmH~2~O/μV)0.6 (0.4-0.9)1.3 (0.8-1.8)1.9 (1.2-2.7)The NAVA level is a proportional gain factor expressed in cmH~2~O/μV of EAdi. It represents the magnitude (in cmH~2~O) of positive airway pressure applied per μV EAdi during the course of each inspiration.PAV, proportion of assistance (%)27 (25--35)55 (50--70)82 (75--95)The proportion of assistance is the percentage of work provided by the ventilator. The rest of the work is provided by the patient.EAdi, electrical activity of the diaphragm; PSV, pressure support ventilation; NAVA, neurally adjusted ventilatory assist; PAV, proportional assist ventilation.Data are provided as median (interquartile range).

Breathing pattern and electrical activity of the diaphragm {#Sec12}
----------------------------------------------------------

Group median values for representative breathing pattern variables are provided in Figure [1](#Fig1){ref-type="fig"} and Figure [2](#Fig2){ref-type="fig"} (see also Additional file [4](#MOESM4){ref-type="media"}). Inspiratory pressures for each patient under all conditions are displayed in Additional file [4](#MOESM4){ref-type="media"}. Median airway pressure was similar among level~100~ and level~150~ groups. Within all assistance levels (level~50~, level~100~, level~150~), P~max~ was higher with NAVA than with PAV and PSV (*P* = 0.001; Figure [1](#Fig1){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}). At level~50~ and level~100~, V~T~ was similar among modes. However, at a high assistance level, V~T~ was significantly higher with PSV~150~ than with NAVA~150~ and PAV~150~ (*P* \< 0.05). Tidal volume was similar with NAVA and PAV regardless of the assistance level. Inspiratory time and RR remained similar within all modes and at each level of assistance. Of note, at level~100,~ and level~150~, EAdi~max~ and EAdi~AUC~ were higher in PAV than in PSV (Figure [2](#Fig2){ref-type="fig"}; Table [3](#Tab3){ref-type="table"}). Whereas the V~T~/EAdi~max~ ratio was similar among groups at level~50~, it was higher with PSV than with PAV at level~100~ and level~150~ (*P* \<0.0001). In addition, the V~T~/EAdi~max~ ratio was higher with PSV (*P* \<0.0001) but did not differ between PAV and NAVA regardless of the assistance level.Figure 1**Impact of ventilator mode and level of assistance on mean (** ***P*** ~***mean***~ **) and maximum airway pressure (** ***P*** ~***max***~ **).** Pressure support ventilation (PSV)~100~, neurally adjusted ventilatory assist (NAVA)~100~, and proportional assist ventilation (PAV)~100~ are medium levels of assistance set to obtain a tidal volume (V~T~) between 6 and 8 ml/kg ideal body weight. PSV~50~, NAVA~50~ and PAV~50~ are low levels of assistance defined by decreasing the assistance level by 50% in each condition. Inversely, PSV~150~, NAVA~150~, and PAV~150~ are defined by increasing the assistance level by 50% in each condition. \**P* \<0.05 with PSV; ^£^ *P* \<0.05 with NAVA. Data are expressed as median and interquartile range.Figure 2**Impact of ventilator mode and level of assistance on the major descriptors of breathing pattern and diaphragmatic electrical activity (EAdi).** Pressure support ventilation (PSV)~100~, neurally adjusted ventilatory assist (NAVA)~100~, and proportional assist ventilation (PAV)~100~ are medium levels of assistance set to obtain a tidal volume (V~T~) between 6 and 8 ml/kg ideal body weight. PSV~50~, NAVA~50~ and PAV~50~ are low levels of assistance defined by decreasing the assistance level by 50% in each condition. Inversely, PSV~150~, NAVA~150~, and PAV~150~ are defined by increasing the assistance level by 50% in each condition. *EAdi* ~*max*~ *,* peak of EAdi; *RR*, respiratory rate; *V* ~*T*~ */Eadi* ~*max*~, neuromechanical coupling. \**P* \<0.05 with PSV. Data are expressed as median and interquartile range.Table 3**Impact of ventilator mode and level of assistance on the main descriptors of breathing pattern and electrical activity of the diaphragm (EAdi)PSVNAVAPAV**P~mean~ (cmH~2~O) level~50~6.8 (6.1-8.7)8.1 (6.3-10.3)6.5 (6.0-8.5)^£^ level~100~9.8 (8.4-13.6)9.6 (7.3-12.7)9.1 (7.9-10.6) level~150~11.4 (9.2-13.4)10.9 (8.0-13.8)10.9 (8.5-13.2)P~peak~ (cmH~2~O) level~50~13.9 (12.4-15.7)19.2 (16.1-22.4)\*16.2 (13.1-17.9)^£^ level~100~20.8 (17.8-22.5)25.4 (19.9-31.4)\*20.5 (18.5-24.1)^£^ level~150~28.4 (22.6-29.7)29.1 (23.4-41.3)\*25.9 (23.4-32.3)^£^Respiratory rate (n.min^−1^) level~50~30 (25--34)28 (25--32)30 (26--34) level~100~24 (19--32)27 (22--30)28 (17--31) level~150~23 (17--25)25 (20--29)26 (18--30)Tidal volume (mL.kg^−1^ IBW) level~50~6.4 (5.4-8.7)6.6 (5.5-9.9)6.0 (4.8-8.4) level~100~7.5 (5.8-8.9)6.9 (5.9-10.3)6.2 (5.4-7.8) level~150~10.9 (8.9-12.0)7.4 (5.9-10.5)\*7.4 (5.7-10.1)\*Minute ventilation (mL.min^−1^) level~50~10.8 (8.9-15.8)9.8 (8.2-14.4)11.0 (7.9-14.5) level~100~10.6 (8.2-14.1)10.0 (9.2-16.6)9.8 (8.0-13.5) level~150~12.5 (9.8-17.3)10.1 (7.8-13.9)11.3 (8.6-14.5)Inspiratory time (sec) level~50~0.72 (0.67-0.82)0.77 (0.60-0.84)0.73 (0.61-0.99) level~100~0.72 (0.67-0.95)0.78 (0.61-0.93)0.76 (0.64-1.06) level~150~0.85 (0.69-1.18)0.79 (0.59-0.93)0.83 (0.64-1.09)EAdi~max~ level~50~9.1 (5.4-26.2)14.3 (5.9-25.0)18.1 (6.4-34.8) level~100~8.7 (3.9-20.9)12.5 (5.1-19.7)13.7 (8.9-27.2)\* level~150~4.7 (2.9-15.1)10.6 (5.3-18.0)10.9 (4.1-13.1)\*EAdi~AUC~ level~50~9.5 (3.9-13.6)9.9 (4.8-16.0)13.2 (4.7-19.9) level~100~7.1 (3.6-13.5)8.5 (4.9-12.3)12.2 (6.2-18.8)\* level~150~4.3 (2.4-8.7)8.9 (4.4-11.4)11.4 (3.3-14.5)\*V~T~ /EAdi~max~ level~50~0.67 (0.27-1.51)0.44 (0.24-1.43)0.40 (0.20-1.01) level~100~0.74 (0.29-2.13)0.62 (0.33-1.64)0.47 (0.25-0.96)\* level~150~1.67 (0.64-3.22)0.83 (0.37-1.60)\*0.54 (0.34-1.68)\*EAdi~max~, peak EAdi; EAdi~AUC~, area under the EAdi curve; P~mean~; mean inspiratory airway pressure; P~max~, maximum inspiratory airway pressure; PSV, pressure support ventilation; PAV, proportional assist ventilation; NAVA, neurally adjusted ventilatory assist.Level~100~ is a medium assistance level set to obtain a VT of 6 to 8 ml/.kg ideal body weight. Level~50~ is a low assistance level defined as level~100~ decreased by 50%. Level~150~ is a high assistance level defined as level~100~ increased by 50%.Data are provided as median (interquartile range).\**P* \<0.05 with PSV; ^£^ *P* \<0.05 with NAVA.

Breath-by-breath variability {#Sec13}
----------------------------

Group median values for coefficient of variation V~T~ and EAdi~max~ are provided in Figure [3](#Fig3){ref-type="fig"} (see also Additional file [5](#MOESM5){ref-type="media"}). The coefficient of variation of V~T~ was higher with PAV and NAVA than with PSV at level~100~ and level~150~ (*P* \<0.05), whereas the coefficient of variation of V~T~ was similar between NAVA and PAV at each level of assistance. Conversely, the coefficient of variation of EAdi~max~ did not change according to ventilator mode and level of assistance, except at level~150~, where it was lower with PAV~150~ than with PSV~150~.Figure 3**Impact of ventilator mode and level of assistance on the coefficient of variation of tidal** ***volume*** **(CV** ~**VT**~ **) and maximum electrical activity of the diaphragm (CV** ~**EAdimax**~ **).** Pressure support ventilation (PSV)~100~, neurally adjusted ventilatory assist (NAVA)~100~, and proportional assist ventilation (PAV)~100~ are medium levels of assistance set to obtain a tidal volume (V~T~) between 6 and 8 ml/kg ideal body weight. PSV~50~, NAVA~50~ and PAV~50~ are low levels of assistance defined by decreasing the assistance level by 50% in each condition. Inversely, PSV~150~, NAVA~150~ and PAV~150~ are defined by increasing the assistance level by 50% in each condition. \**P* \<0.05 with PSV; ^£^ *P* \<0.05 with NAVA; Data are expressed as median and interquartile range.

Patient-ventilator interaction {#Sec14}
------------------------------

Table [4](#Tab4){ref-type="table"} and Additional file [6](#MOESM6){ref-type="media"} show the inspiratory and expiratory trigger delays, the correlation between both V~T~ and P~max~ and EAdi, and the prevalence of patient-ventilator asynchrony in each condition. Inspiratory trigger delay was significantly lower in NAVA than in PAV and PSV at level~100~ and level~150~, respectively. Similarly, expiratory trigger delay was lower during NAVA~100~ and NAVA~150~ than during PSV~100~ and PSV~150~, respectively (Table [4](#Tab4){ref-type="table"}). The correlation between EAdi~AUC~ and V~T~, was higher during NAVA and PAV than during PSV (Table [4](#Tab4){ref-type="table"}). The correlation between EAdi~max~ and P~max~ was higher during NAVA than during PAV and PSV (Table [4](#Tab4){ref-type="table"}). At each level of assistance, almost no ineffective efforts were reported with PAV and NAVA, whereas the ineffective efforts were detected with PSV at a higher level (*P* \<0.05). Inversely, although very few double-triggering events were observed with PSV and PAV, the prevalence of double triggering was significantly higher with NAVA (*P* \<0.05, Table [4](#Tab4){ref-type="table"}). Type II double triggering was due to ventilator cycled off when the EAdi dropped to 70% of its peak, followed by a rebound in inspiratory flow, cause of the retriggering, when cycled off to PEEP (see Additional file [3](#MOESM3){ref-type="media"}).Table 4**Impact of ventilator mode and level of assistance on patient-ventilator interaction and asynchrony indicesPSVNAVAPAV**Inspiratory trigger delay (msec) level~50~162 (109--241)157 (138--289)185 (140--305) level~100~170 (140--282)124 (100--238)224 (176--280)^£^ level~150~266 (140--427)164 (99--278)\*201 (166--317)Expiratory trigger delay (msec) level~50~156 (112--191)151 (125--175)152 (107--175) level~100~212 (176--273)157 (140--188)\*182 (116--230) level~150~255 (227--541)146 (131--218)\*225 (169--333)Relationship between P~max~ and EAdi~max~ (r^2^) level~50~0.02 (0.01-0.04)0.56 (0.51-0.65)\*0.02 (0.00-0.04)^£^ level~100~0.03 (0.01-0.08)0.85 (0.78-0.90)\*0.04 (0.00-0.07)^£^ level~150~0.03 (0.01-0.06)0.64 (0.43-0.88)\*0.03 (0.02-0.08)^£^Relationship between V~T~ and EAdi~AUC~ (r^2^) level~50~0.15 (0.14-0.19)0.48 (0.40-0.57)\*0.39 (0.25-0.45)\* level~100~0.13 (0.06-0.22)0.64 (0.60-0.79)\*0.29 (0.21-0.42) level~150~0.02 (0.01-0.06)0.72 (0.65-0.88)\*0.28 (0.25-0.41)\*Ineffective efforts (n.min^−1^) level~50~0.00 (0.00-0.07)0.00 (0.00-0.00)\*0.00 (0.00-0.00)\* level~100~0.03 (0.00-0.26)0.00 (0.00-0.00)\*0.00 (0.00-0.00)\* level~150~0.27 (0.01-1.23)0.00 (0.00-0.00)\*0.00 (0.00-0.00)\*Auto-triggering (n.min^−1^) level~50~0.00 (0.00-0.03)0.00 (0.00-0.00)0.00 (0.00-0.00) level~100~0.00 (0.00-0.03)0.00 (0.00-0.00)0.00 (0.00-0.00) level~150~0.00 (0.00-0.00)0.00 (0.00-0.00)0.00 (0.00-0.00)Double triggering (n.min^−1^) level~50~0.00 (0.00-0.00)0.42 (0.08-0.50)\*0.00 (0.00-0.00)^£^ level~100~0.00 (0.00-0.18)0.33 (0.10-0.92)\*0.00 (0.00-0.10)^£^ level~150~0.00 (0.00-0.21)0.30 (0.02-0.87)\*0.00 (0.00-0.20)^£^Asynchrony index (%) level~50~0.21 (0.00-0.65)1.41 (0.34-2.91)\*0.13 (0.00-0.44)^£^ level~100~0.61 (0.04-1.28)1.73 (0.38-2.69)0.00 (0.00-0.58)^£^ level~150~1.65 (0.58-5.77)1.17 (0.05-3.99)0.19 (0.00-1.12)EAdi~AUC~, area under the diaphragmatic electrical activity curve; PSV, pressure support ventilation; NAVA, neurally adjusted ventilatory assist; PAV, proportional assist ventilation; VT, tidal volume. Level~100~ is a medium assistance level set to obtain a VT of 6to 8 ml/kg ideal body weight. Level~50~ is a low assistance level defined as level~100~ decreased by 50%. Level~150~ is a high assistance level defined as level~100~ increased by 50%.The number of each type of asynchrony is reported as the total number of each event per minute. Asynchrony index is defined as the total number of asynchrony events × 100/(ventilator respiratory rate + ineffective efforts).\**P* \<0.05 with PSV; ^£^ *P* \<0.05 with NAVA; data are expressed as median (interquartile range).

No autotriggering was observed in any condition. Overall, the asynchrony index was significantly lower with PAV~50~ and PAV~100~ than with NAVA~50~ and NAVA~100~, respectively (P \< 0.05). Of note, only two patients exhibited an AI \>10% in PSV~150~, mostly due to a high number of ineffective efforts (patients 7 and 14). Dyspnea was able to be evaluated in only two patients because of insufficient cooperation (data not shown).

Gas exchange {#Sec15}
------------

Neither the mode (PSV, NAVA, PAV) nor the level of assistance (level~50,\ 100,\ 150~) influenced PaO~2~, PaCO~2~, or pH, which remained not significantly different between all conditions, except for PaCO~2~ that was higher and pH that was lower with PAV~100~, than with NAVA~100~ (see Additional file [7](#MOESM7){ref-type="media"} for detailed blood gas values).

Discussion {#Sec16}
==========

The main findings of our study are as follows: (1) PAV and NAVA both prevented overassistance-induced hyperinflation, in contrast with PSV; (2) PAV and NAVA restored a comparable level of breathing-pattern variability that was greater than the variability observed with PSV; (3) Regardless of the level of assistance, PAV and NAVA induced less patient-ventilator asynchrony than PSV, with the exception of double triggering, which was more frequent with NAVA. The similarities observed between NAVA and PSV in terms of breathing pattern, variability, and asynchrony are consistent with the conceptual similarities of these two modes.

Breathing pattern and central respiratory neural output {#Sec17}
-------------------------------------------------------

Increasing PSV assist levels were associated with increasing V~T~ values, in keeping with previous data \[[@CR29],[@CR30]\]. In contrast, V~T~ remained stable with NAVA and PAV, despite increasing assist levels \[[@CR12],[@CR31]\], suggesting that these modes protect against overdistention. With PSV, the end of the patient's inspiratory effort does not determine cycling-off of the ventilator. A patient may therefore trigger a PSV breath with a small inspiratory effort, then relax, and be passively insufflated. If this breath is given at an excessive assist level, the insufflation may continue while the patient has already stopped inspiring. In contrast, with PSV, NAVA and PAV deliver an insufflation that stops when either the output of the inspiratory centers to the diaphragm ends, in the case of NAVA (12), or when the inspiratory muscle activity ends, in the case of PAV.

In addition, because overdistention contributes to downregulate the activity of respiratory control centers (29), tidal volume is maintained constant with PAV and NAVA but not with PSV. The robustness of this protective biofeedback provided by proportional modes, as opposed to PSV, is illustrated in the present study by the marked alteration of the coupling between V~T~ and EAdi~*max*~ (that is, higher V~T~ /EAdi ratio) observed with PSV at high levels of assistance (see Figure [2](#Fig2){ref-type="fig"}), which was not observed with the two proportional modes.

Breath-by-breath variability {#Sec18}
----------------------------

Fluctuations in the resting breathing pattern of healthy humans have been known for a long time \[[@CR32]\]. Breathing pattern variability seems to originate from the activity of central pattern generators \[[@CR33]\]. It is further influenced by the load--capacity relationship of the respiratory system: the higher the loading, the lower the variability \[[@CR19],[@CR34],[@CR35]\].

In the present study, the variability of V~T~ with NAVA and PAV was greater than with PSV at each assistance level. In contrast, the variability of EAdi was similar between the three modes, except at high assistance level. These data indicate that the increase in breath-to-breath variability observed during NAVA and PAV is actually due to "unmasking" of the underlying variability in central respiratory neural output and is a direct result of improvement of neuromechanical coupling. To our knowledge, these data, previously described in NAVA \[[@CR19]\], have never been described with PAV. They suggest that PAV and NAVA both improve neuromechanical coupling in similar ways.

Patient-ventilator interaction {#Sec19}
------------------------------

As previously observed, NAVA and PAV improved patient-ventilator synchrony as compared with PSV \[[@CR12],[@CR21],[@CR22],[@CR24],[@CR25],[@CR31]\]. Although inspiratory trigger delays in all modes were consistently greater than previously reported \[[@CR11],[@CR36],[@CR37]\], lower inspiratory and expiratory trigger delays seemed to be more frequently noted in NAVA. Wide variability of the delays (see Additional file [6](#MOESM6){ref-type="media"}) and their greater values can be ascribed to different ventilators used, varying levels of assist provided, experimental settings themselves, and the different etiologies of respiratory failure. It is noteworthy that, in the present study, PAV and NAVA provided a similar benefit on ineffective triggering. It suggests that PAV and NAVA improve the relationship between EAdi and tidal volume in a similar way, which in turn prevents chest hyperinflation, a major risk factor for ineffective triggering \[[@CR7]\].

Two types of double triggering have been described in NAVA \[[@CR25]\]. Type I double triggering is the result of a biphasic EAdi signal, but its significance is unknown, which is why, strictly speaking, it cannot be considered to be patient--ventilator asynchrony. With type II double triggering, however, one neural inspiration triggers two breaths, which was due to ventilator cycle off when the EAdi dropped to 70% of its peak, followed by a rebound in inspiratory flow, cause of the re/-triggering, when cycled off to PEEP. Pneumatic trigger set to pressure instead of flow might limit the rebound in inspiratory flow. We therefore considered only type II double triggering in the present study and observed that this asynchrony was significantly more frequent with NAVA than with PSV and PAV. The relevance of this asynchrony and how to decrease its prevalence in NAVA need further investigations \[[@CR25]\].

The correlation between V~T~ and EAdi~AUC~ was much weaker in PSV than in NAVA or PAV, whereas no significant difference was found between NAVA and PAV, which demonstrates that these two modes provide an assistance that is proportional to the central respiratory drive. This is consistent with the recent report from Akoumianaki *et al.* \[[@CR38]\], showing that the correlation between the inspiratory integral of transdiaphragmatic pressure and the V~T~ was weaker with NAVA than with PAV \[[@CR38]\]. Interestingly, the correlation between EAdi~max~ and P~max~ was higher in NAVA than in PAV, which may have two distinct explanations. First, during NAVA, EAdi and airway pressure are by definition strictly proportional and a strong correlation between EAdi~max~ and P~max~ is intrinsic to NAVA. Second, as opposed to NAVA that delivers an assistance proportional to the only diaphragm activity, PAV delivers an assistance that is proportional to the whole inspiratory activity of respiratory muscles. As a consequence, PAV integrates not only diaphragm activity, but also the activity of extradiaphragmatic inspiratory muscles such as scalenes or parasternal intercostal muscles \[[@CR39]\].

Limitations of the study {#Sec20}
------------------------

Our study has several limitations. First, as patients at high risk of asynchrony (for example, difficult-to-wean or severe COPD patients) were not specifically selected in this study \[[@CR7]\] and because we targeted a V~T~ of 6 to 8 ml/kg in level~100~ \[[@CR40]\], a very low incidence of asynchrony was observed with all modes and conditions. This study may therefore have underestimated the benefits of NAVA and PAV \[[@CR20],[@CR39],[@CR41],[@CR42]\], but we deliberately decided to compare these modes in patients in the recovery phase after acute respiratory failure encountered in daily practice rather than in a very selected population, with the risk of showing results that would be transposable only to a niche population.

Second, the trials in our study were probably not sufficiently long to allow an improvement of gas exchange. This might explain why, despite a greater variability of the breathing pattern in PAV and NAVA, no impact on PaO~2~ was observed in contrast with previously published results \[[@CR14]\].

Third, the choice of a resulting V~T~ of 6 to 8 ml/kg to match the assistance level~100~ with the three modes may be questionable. Indeed, a poor correlation between V~T~ and PAV %Assist \[[@CR43]\] as well as NAVA level \[[@CR18]\] has been reported. In addition, the high V~T~ variability may have jeopardized the accuracy of its setting. However, the fact that we observed a comparable P~mean~ with the three modes at assistance level~100~ suggests that the patients received a comparable level of assistance.

Fourth, because we focused on patients in the recovery phase after acute respiratory failure and because PSV~50~ could not be lower than 7 cmH~2~O, PSV~100~ settings could sometimes be very close to PSV~50~.

Fifth, although the expiration starts at 70% of the EAdi~max~ in NAVA, the expiratory trigger delay was calculated as the time difference between EAdi~max~ and the end of insufflation by the ventilator within the three modes. Finally, contrary to the sequence of the ventilatory modes tested, the sequence of the level of assistance was not randomized. Therefore, we cannot rule out a potential time effect.

Clinical implications {#Sec21}
---------------------

Most of our findings are potentially clinically relevant. Lung-protective ventilation has become a major concern in ICU patients, even in those without acute respiratory distress syndrome \[[@CR44],[@CR45]\]. Preventing alveolar overdistention and subsequent volotrauma caused by lung hyperinflation is now a major therapeutic goal. In this respect, NAVA and PAV provide an interesting tool to prevent overassistance-induced hyperinflation.

Variability of breathing pattern has become a matter of concern in ICU patients, as a recent study showed that a higher variability of respiratory rate was associated with better prognosis \[[@CR46]\]. In addition, a more variable breathing pattern is associated with better pulmonary function in animal models of lung injury \[[@CR47]-[@CR51]\]. Finally, severe patient-ventilator asynchrony is associated with longer duration of mechanical ventilation and a greater need for tracheostomy \[[@CR7]\]. Of note, patient-ventilator asynchrony may be either a cause or a consequence of the severity of the respiratory disease requiring mechanical ventilation. Whether optimization of ventilatory settings, by using PAV or NAVA, can shorten the duration of mechanical ventilation by reducing the incidence of asynchrony, has therefore not been demonstrated.

Conclusion {#Sec22}
==========

In conclusion, PAV and NAVA both prevent overdistention and improve neuromechanical coupling and patient-ventilator asynchrony in fairly similar ways compared with PSV. Further studies are needed to evaluate the possible clinical benefits of NAVA and PAV on clinical outcomes, especially in the recovery phase of acute respiratory failure.

Key messages {#Sec23}
============

The variability of V~T~ with NAVA and PAV is greater than with PSV at each assistance level.PAV and NAVA both restore "natural" variability of breathing.The increase in breath-to-breath variability observed during NAVA and PAV is due to "unmasking" of the underlying variability in central respiratory neural output and is a direct result of improvement of neuromechanical coupling.NAVA and PAV both improve patient-ventilator synchrony as compared with PSV, especially on ineffective triggering.

Additional files {#Sec24}
================

Additional file 1:**Waveforms of EAdi, pressure and flow for all three modes (PSV** ~**100**~ **, NAVA** ~**100**~ **, PAV** ~**100**~ **) in the same patient.**Additional file 2:**Definitions of patient- ventilator interaction indices and the main asynchronies collected.**Additional file 3:**Example of Type II double triggering under NAVA.**Additional file 4:**Inspiratory pressure (cmH** ~**2**~ **O) over PEEP for each patient under the three modes and three assist levels.**Additional file 5:**Impact of ventilator mode and assistance level on the coefficients of variation of neural respiratory rate, tidal volume, and peak electrical activity of the diaphragm (EAdi** ~**max**~ **).**Additional file 6:**Distribution of the inspiratory trigger delays per mode.**Additional file 7:**Impact of ventilator mode and level of assistance on gas exchange.**

**Competing interests**

The *Association pour le Développement et l\'Organisation de la Recherche en Pneumologie*, a nonprofit structure that supports the research activities of the "Service de Pneumologie et Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière," has received an unrestricted research grant from Maquet France SA, Orléans, France (2009), and Covidien, Dublin, Ireland (2013), to support pathophysiological research studies on NAVA and PAV, respectively. A. Demoule is the principal investigator of a study on NAVA, has been a consultant for Covidien, and has given lectures for Covidien and Maquet. The others authors have no conflict of interest.

**Authors' contributions**

MS conceived the study and contributed to the data collection, analysis, statistics, and writing of the manuscript. FK contributed to the data collection and analysis. JC contributed to data collection and analysis. TP contributed to the data analysis and the revision of the manuscript. EM contributed to the data collection, their analysis, and the revision of the manuscript. RP contributed to the data collection and revised the manuscript. TS drafted the design of the study, and contributed to the writing and the revision of the manuscript. AD conceived the study and contributed to the data collection, analysis, statistics, and writing of the manuscript. All authors read and approved the manuscript.

**Authors' information**

Dr Matthieu Schmidt *is an ICU physician.*

Dr Felix Kindler *is an ICU physician.*

Dr Jérôme Cecchini *is an ICU physician.*

Dr Elise Morawiec *is an ICU physician.*

Dr Romain Persichini *is an ICU physician.*

Pr Thomas Similowski *is a Professor of Pulmonology. He is the chair of the Department of Pulmonology and Medical ICU in La Pitie Salpetriere hospital in Paris.*

Pr Alexandre Demoule is a Professor of intensive care*.*

Matthieu Schmidt was supported by the French Intensive Care Society (SRLF); the "*Fonds de dotation Recherche en Santé Respiratoire 2012*" the "*Collège des Enseignants de Réanimation Médicale*" and the "Fonds d\'Etudes et de Recherche du Corps Médical-Assistance Publique des Hôpitaux de Paris".

Written informed consent was obtained from the patients for publication of their individual details and accompanying images in this manuscript. The consent form is held by the authors and is available for review by the Editor-in-Chief.
